These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 3738461)

  • 1. [Renal lithiasis: the internist's viewpoint 1986].
    Jaeger P
    Schweiz Med Wochenschr; 1986 Jul; 116(27-28):902-8. PubMed ID: 3738461
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Physiological and physiochemical correction and prevention of calcium stone formation by potassium citrate therapy.
    Pak CY; Sakhaee K; Fuller CJ
    Trans Assoc Am Physicians; 1983; 96():294-305. PubMed ID: 6679957
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Comparative study of urinary calcium, oxalate and uric acid in calcium oxalate lithiasis].
    Dumoulin G; Haton D; Wolf JP; Henriet MT; Nguyen NU; Mougin C; Saint-Hillier Y; Combes M; Berthelay S
    Nephrologie; 1984; 5(5):189-91. PubMed ID: 6531054
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Incidence of hyperoxaluria in idiopathic calcium nephrolithiasis].
    Jaeger P; Portmann L; Bugnon JM; Jacquet AF; Burckhardt P
    Schweiz Med Wochenschr; 1982 Dec; 112(49):1795-8. PubMed ID: 7178877
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Calcium lithiasis: uric acid under question].
    Petit C
    Nephrologie; 1984; 5(5):192-4. PubMed ID: 6531055
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Body size and 24-hour urine composition.
    Taylor EN; Curhan GC
    Am J Kidney Dis; 2006 Dec; 48(6):905-15. PubMed ID: 17162145
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urinary risk factors for recurrent calcium stone formation in Thai stone formers.
    Stitchantrakul W; Kochakarn W; Ruangraksa C; Domrongkitchaiporn S
    J Med Assoc Thai; 2007 Apr; 90(4):688-98. PubMed ID: 17487123
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Functional evaluation in patients with kidney calculi].
    Stojimirović B
    Srp Arh Celok Lek; 1998; 126(9-10):394-8. PubMed ID: 9863414
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolic abnormalities associated with calyceal diverticular stones.
    Auge BK; Maloney ME; Mathias BJ; Pietrow PK; Preminger GM
    BJU Int; 2006 May; 97(5):1053-6. PubMed ID: 16643491
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Metabolic changes in 2612 patients with nephrolithiasis].
    del Valle E; Spivacow R; Zanchetta JR
    Medicina (B Aires); 1999; 59(5 Pt 1):417-22. PubMed ID: 10684159
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effect of cocoa on excretion of oxalate, citrate, magnesium and calcium in the urine of children].
    Lagemann M; Anders D; Graef V; Bödeker RH
    Monatsschr Kinderheilkd; 1985 Oct; 133(10):754-9. PubMed ID: 4069117
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A retrospective analysis of the metabolic status of stone formers in the New York City metropolitan areas.
    Hatch M; Schepers A; Grunberger I; Godec CJ
    N Y State J Med; 1991 May; 91(5):196-200. PubMed ID: 1857571
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Studies of urinary risk factors in urolithiasis].
    Ebisuno S; Kitagawa M; Morimoto S; Miyazaki Y; Minakata S; Yasukawa S; Fukatani T; Ohkawa T
    Hinyokika Kiyo; 1985 Jan; 31(1):1-15. PubMed ID: 3993484
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factors increasing the risk for stone formation in adult patients with cystic fibrosis.
    Terribile M; Capuano M; Cangiano G; Carnovale V; Ferrara P; Petrarulo M; Marangella M
    Nephrol Dial Transplant; 2006 Jul; 21(7):1870-5. PubMed ID: 16595587
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Urine composition in type 2 diabetes: predisposition to uric acid nephrolithiasis.
    Cameron MA; Maalouf NM; Adams-Huet B; Moe OW; Sakhaee K
    J Am Soc Nephrol; 2006 May; 17(5):1422-8. PubMed ID: 16597681
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Causes of hypocitraturia in recurrent calcium stone formers: focusing on urinary potassium excretion.
    Domrongkitchaiporn S; Stitchantrakul W; Kochakarn W
    Am J Kidney Dis; 2006 Oct; 48(4):546-54. PubMed ID: 16997050
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Experimental and clinical studies on calcium lithiasis. II. Prevention of recurrent calcium stones with thiazides and allopurinol].
    Okada Y; Nonomura M; Takeuchi H; Kawamura J; Yoshida O
    Hinyokika Kiyo; 1986 Sep; 32(9):1247-57. PubMed ID: 3812144
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical significance of hypocitraturia in kidney stone patients.
    Matsushita K; Tanikawa K; Masuda A; Matsuzaki S
    Nihon Jinzo Gakkai Shi; 1993 Nov; 35(11):1253-7. PubMed ID: 8139138
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes in urinary stone risk factors in hypocitraturic calcium oxalate stone formers treated with dietary sodium supplementation.
    Stoller ML; Chi T; Eisner BH; Shami G; Gentle DL
    J Urol; 2009 Mar; 181(3):1140-4. PubMed ID: 19152919
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Urolithiasis in adults. Clinical and biochemical aspects.
    Abdel-Halim RE
    Saudi Med J; 2005 May; 26(5):705-13. PubMed ID: 15951854
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.